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        Introduction 
  The delicate leafl  ets of the heart valves act as gatekeepers 
to navigate blood fl  ow through the heart and great vessels. 
As the embryonic heart begins the morphogenic process of 
looping, endocardial cushions, protrusions of complex extra-
cellular matrix and proteoglycans, develop between the layers 
of the bilaminar heart tube and serve as the primordial car-
diac valves. After formation, endocardial (cardiac endothelial) 
cells that overlie the cushions undergo epithelial to mesen-
chymal transition (EMT) in response to inductive factors se-
creted by the juxtaposing myocardium. The newly formed 
mesenchymal cells disperse within the cushions and undergo 
terminal differentiation into valvular fi  broblasts. Subsequently, 
remodeling events resolve the cushions into slender valve 
leafl  ets and the membranous portion of the chamber septa. 
Disturbances during these morphogenetic events contribute 
to the etiology of a spectrum of anomalies (ventricular septal 
defect; tetralogy of Fallot; pulmonic and aortic valve atresia, 
or stenosis; and double outlet right ventricle) affecting    1%  of 
live births and carrying a signifi  cant mortality (for review see 
 Hoffman,  1995 ). 
  Experiments in vertebrate models and the atrioventricu-
lar canal (AVC) explant assay revealed that TGF-   ,  Notch, 
nuclear factor of activated T cells, VEGF, and Wnt/   -catenin 
are involved at discrete stages of valvulogenesis (  Person et al., 
2005  ). However, the pathogenetic mechanisms leading to the 
structural abnormalities observed in human congenital heart 
defects remain largely unknown. To date, little information 
regarding the role of the interleukin 6 (Il-6) superfamily in 
EMT has been published except for a handful of studies. 
In mononuclear cells, oncostatin M (OSM) induces epithelial 
cell to myofi  broblast transdifferentiation, a process similar to 
EMT, and in human breast carcinoma cells, OSM results in 
acquisition of a mesenchymal morphology and an invasive 
phenotype (  Nightingale et al., 2004; Jorcyk et al., 2006  ). 
A role for Il-6 in breast cancer cell motility via the down-
  regulation of epithelial cadherin (a necessary and suffi  cient step 
in EMT) and the acquisition of fi  broblastoid morphology has 
been reported (  Asgeirsson et al., 1998  ). To our knowledge, 
  B
lood circulation is dependent on heart valves to di-
rect blood ﬂ  ow through the heart and great vessels. 
Valve development relies on epithelial to mesenchy-
mal transition (EMT), a central feature of embryonic develop-
ment and metastatic cancer. Abnormal EMT and remodeling 
contribute to the etiology of several congenital heart de-
fects. Leptin and its receptor were detected in the mouse 
embryonic heart. Using an ex vivo model of cardiac EMT, 
the inhibition of leptin results in a signal transducer and 
activator of transcription 3 and Snail/vascular endothelial 
cadherin  –  independent decrease in EMT and migration. 
Our data suggest that an Akt signaling pathway underlies 
the observed phenotype. Furthermore, loss of leptin pheno-
copied the functional inhibition of     v    3 integrin receptor 
and resulted in decreased     v    3 integrin and matrix me-
talloprotease 2, suggesting that the leptin signaling path-
way is involved in adhesion and migration processes. This 
study adds leptin to the repertoire of factors that mediate 
EMT and, for the ﬁ  rst time, demonstrates a role for the 
  interleukin 6 family in embryonic EMT.
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during advanced congestive heart failure, indicating patho-
logical roles of leptin in the cardiovascular system (  Meisel 
et al., 2001  ;   Schulze et al., 2003  ). The precise functions of 
leptin may be varied and complex, as leptin administration 
after ischemia reperfusion is cardioprotective via an Akt  –
  phosphoinositide-3 kinase (PI3K) pathway (  Smith et al., 2006  ). 
Collectively, these data underscore the pleiotropic character-
istic of this cytokine. 
  A diverse array of biological actions for leptin has been 
revealed by the   ob/ob   mouse. These mice display a phenotype 
of obesity, hypothermia, hyperinsulinemia, hyperglycemia, and 
sterility, but reproductive function, body weight, and metabolic 
status return to normal with the administration of recombinant 
leptin (  Coleman, 1978; Campfi  eld et al., 1995  ;   Chehab et al., 
1996  ). Additional defects occur in immune response, infl  amma-
tion, hematopoiesis, angiogenesis, and bone growth/development 
(  Fantuzzi and Faggioni, 2000  ;   Murad et al., 2003  ;   Thomas, 
2004 ).  Leptin-defi  cient mice are viable, although the adminis-
tration of recombinant leptin is required during conception, 
pregnancy, and nursing for fertility, maintenance of pregnancy, 
and lactation (  Mantzoros and Moschos, 1998; Malik et al., 
2001  ). Thus, recombinant leptin from the maternal circulation 
may mask the effects of leptin defi   ciency on early post-
implantation embryonic development in   ob/ob   mice.  Alterna-
tively, given the propensity for compensation in mice, other Il-6 
members such as cardiotrophin or OSM may be induced, or 
pathways downstream of leptin may be hyperactivated, re-
sulting in normal development.   db/db   mice carry a mutation 
that results in a truncated leptin receptor incapable of Janus ki-
nase (JAK)/signal transducer and activator of transcription 
(STAT) signaling and display a similar phenotype to   ob/ob  
mice. However, endothelial and mesangial cells from   db/db  
mice are capable of responding to leptin via alternative signal-
ing pathways, raising the possibility that leptin engagement of 
the short form of the receptor occurs during in utero develop-
ment in this strain (  Han et al., 2001  ). 
  Of note, oocytes and preimplantation embryos express 
leptin and leptin receptor, which function in oocyte polarity, 
preimplantation development, and implantation (  Antczak and 
Van Blerkom, 1997  ;   Kawamura et al., 2002  ;   Cervero et al., 
2005  ;   Herrid et al., 2006  ;   Yang et al., 2006  ). The infl  uence of 
leptin on postimplantation mammalian embryonic development 
has not been fully explored. Accordingly, this study was de-
signed to determine leptin involvement in cardiac EMT and 
to explore the underlying cell signaling pathways engaged. 
Furthermore, known mediators of differentiation and migration 
were evaluated to identify the downstream participants targeted 
by the leptin cascade. In this study, we demonstrate the presence 
of leptin and leptin receptor in the cardiac endocardial cushion 
throughout the process of valvulogenesis. Neutralization of leptin 
or inhibition of Akt in the AVC explant assay resulted in de-
creased total cell number, inhibition of EMT, increased cell 
death, and attenuated migration. Furthermore, these treatments 
result in the failure of    v   3 integrin receptor induction and de-
creased matrix metalloprotease 2 (MMP2), suggesting a leptin 
signaling pathway in endocardial adhesion, EMT, and migra-
tion processes in the developing heart. 
studies involving other Il-6 members (cardiotropin, leukemia 
inhibitory factor, granulocyte colony-stimulating factor, and 
leptin) have not been reported in any developmental or patho-
logical EMT event. 
  In this study, we explore the role of the pleiotropic cyto-
kine leptin in development of the endocardial cushion during 
valvulogenesis. Of the Il-6 family members, leptin became an 
attractive target because of its known roles in endothelial cell 
biology and induction during cardiovascular diseases. Leptin 
guides endothelial cell migration and organization into vascu-
lar structures (  Sierra-Honigmann et al., 1998; Park et al., 2001  ; 
  Goetze et al., 2002  ). Additionally, leptin elicits several physio-
logical responses in the cardiovascular system that infl  uence 
vascular tone, blood pressure, and heart rate (  Haynes et al., 
1997  ;   Shek et al., 1998; Nickola et al., 2000  ).   ob/ob   mice 
(a spontaneous mutation in   leptin  ) develop left ventricular 
hypertrophy independently of body weight that is completely 
reversed with leptin treatment, suggesting antihypertrophic 
properties for leptin (  Barouch et al., 2003  ). However, plasma 
leptin levels increase after acute myocardial infarction and 
  Figure 1.       Spatiotemporal localization of leptin during endocardial cush-
ion morphogenesis.   Immunoﬂ  uorescence staining (red) for leptin was per-
formed on embryonic hearts excised at E8.5 (A), E9.0 (B), E9.5 (C), E10.5 
(D), E11.5 (E), and E12.5 (F). DAPI, blue. Myo, myocardium; En, endo-
cardium; Mes, mesenchyme; CJ, cardiac jelly. Insets are enlargements of 
the endothelium overlaying the endocardial cushion (A), the myocardium 
adjacent to the endocardial cushion (B), and the mesenchymal cells within 
the endocardial cushion (E).     369 LEPTIN MODULATES CARDIAC EMT   •   NATH ET AL.
members, leptin has not been reported to bind structurally simi-
lar cytokine receptors, although this possibility remains. 
  Sequestration of leptin abrogates 
endocardial commitment to and 
completion of EMT 
 Progress in our understanding of the molecular events that under-
lie cardiac EMT has been derived from an ex vivo model that 
mimics the spatiotemporal, molecular, and biochemical events 
that are observed during in vivo valvulogenesis and provides a 
system amenable to experimental manipulation (  Bernanke and 
Markwald, 1982  ;   Runyan and Markwald, 1983  ). In this model, 
the AVC segment is excised before EMT; the cushion tissue is 
exposed and placed onto the surface of a collagen gel matrix. 
Endocardial cells migrate onto the surface of the collagen gel 
and away from the explants. Subsequently, in response to induc-
tive myocardial-derived signals, a subset of the endothelial cells 
undergoes EMT and invades the collagen gel. Cells undergoing 
EMT follow a semilinear progression of morphological changes, 
including (1) lateral cell  –  cell separation from epithelial sheets, 
  Results 
  Spatiotemporal distribution of leptin and 
leptin receptor during endocardial 
cushion morphogenesis 
  A series of immunofl  uorescence images from embryonic day (E) 
8.5 – 12.5 hearts, representing stages through the formation of endo-
cardial cushion protrusions to the remodeling of endocardial mes-
enchyme, was captured to evaluate leptin distribution during 
valvulogenesis. At E8.5, as the myocardium secretes matrix mole-
cules, swelling the extracellular space between the myocardial and 
endocardial layers, leptin presence is strong in the myocardium 
throughout the heart, including the trabeculating myocardium in 
the common ventricle (  Fig. 1 A  ). The endocardium over the endo-
cardial cushions and throughout the heart possesses a weakly de-
tectable level of leptin (  Fig. 1 A  , inset). Induction of EMT begins 
shortly after formation of the acellular endocardial cushions. As the 
fi  rst few cells delaminate from the endocardial layer (E9.0), the 
punctuate pattern of leptin decreases in the myocardium (  Fig. 1 B  , 
inset), but expression begins to appear in the newly formed mesen-
chymal cells (  Fig. 1 C  ). At the later stages of endocardial cushion 
morphogenesis (E9.5  –  12.5), myocardial expression continues to 
abate; however, expression in the endocardium and mesenchymal 
cells increases during stages of active EMT (  Fig. 1, C and D  ), pro-
liferation (  Fig. 1 E  ), and early remodeling (  Fig. 1 F  ), displaying an 
increasingly fi  lamentous pattern (  Fig. 1 E,   inset). The dynamic ex-
pression of leptin throughout endocardial cushion morphogenesis 
suggests regulatory roles in early EMT events such as myocardial 
induction of EMT and maintenance of EMT as well as in later 
migratory roles in the remodeling cushion. 
  Leptin receptor was evaluated using an antibody directed to-
ward the intracellular domain of the long form of the receptor. 
Although the short forms of the receptor have signaling capabil-
ities, they are generally thought to mediate leptin internalization for 
degradation, leptin transport across cell barriers, such as the blood 
brain barrier, or to serve as a soluble form of the receptor upon pro-
teolytic cleavage of the extracellular domain (  Uotani et al., 1999; 
Hileman et al., 2000  ;   Ge et al., 2002  ). In the acellular expanding 
endocardial cushion ( Fig. 2, A and B ), there is cytoplasmic staining 
and strong perinuclear expression in the myocardium (  Fig. 2   A, 
inset) and endocardium (  Fig. 2 B,   inset). This pattern is consis-
tent with a published study on leptin receptor cellular localization 
(  Lundin et al., 2000  ). In Ob-R  –  transfected COS cells, the majority 
of leptin receptors (75  –  95%) localize intracellularly, residing 
within the endoplasmic reticulum and Golgi (  Lundin et al., 2000  ). 
Similar to leptin ligand, leptin receptor decreases in the myocar-
dium as morphogenesis progresses (  Fig. 2, C  –  F  ). 
  Endocardial leptin receptor is detected at E8.5 (  Fig. 2 A  ) 
and peaks at E9.0 (  Fig. 2 B  , inset) just as the fi  rst few mesen-
chymal cells appear, suggesting a role for leptin receptor en-
gagement in the initiation of EMT. During active EMT (  Fig. 2, 
C and D  ; inset), leptin receptor expression abates, whereas in 
the later stages of morphogenesis (  Fig. 2, E and F  ), leptin recep-
tor is only faintly present in the mesenchymal and endocardial 
cells. The weak expression of leptin receptor and strong expres-
sion of leptin in the mesenchymal cells at E11.5  –  12.5 suggests 
a mechanism to limit leptin signaling. In contrast to other Il-6 
  Figure 2.       Spatiotemporal localization of leptin receptor during endocar-
dial cushion morphogenesis.   Immunoﬂ  uorescence staining (red) for leptin 
receptor was performed on embryonic hearts excised at E8.5 (A), E9.0 (B), 
E9.5 (C), E10.5 (D), E11.5 (E), and E12.5 (F). DAPI, blue. Myo, myo-
cardium; En, endocardium; Mes, mesenchyme; CJ, cardiac jelly. Insets are 
enlargements of the myocardium adjacent to the endocardial cushion (A), 
the endothelium overlaying the endocardial cushion (B), and the mesenchy-
mal cells within the endocardial cushion (D).     JCB • VOLUME 181 • NUMBER 2 • 2008  370 
tween cells). However, the percentage of total cells that undergo 
EMT decreased to 23% with leptin antibody treatment compared 
with 67% of IgG control (number of mesenchymal cells = 32.6   ±   
8.6 vs. 214.0   ±   30.9; P = 0.0002;   Fig. 3 A  , gray bars). 
  Cells undergoing EMT display a distinct cellular mor-
phology that can be evaluated by fi  lamentous actin (F-actin) 
distribution. Hallmarks of EMT include increased stress fi  bers 
and focal adhesions concomitant with decreased cell  –  cell junc-
tions. Treatment with leptin antibody resulted in a failure of in-
duction of changes in cell morphology normally associated with 
EMT. The majority of cells appeared rounded with a cortical 
(2) single, rounded cells subsequently elongate on the surface of 
the collagen gel, and (3) elongated cells invade into and migrate 
through the collagen gel. 
  The effects of leptin neutralization on EMT were evaluated 
by the addition of 5  –  20   μ  g/ml leptin antibody or isotype control 
IgG to the media bathing the explants. Leptin sequestration re-
sulted in a signifi  cant decrease (    60%) in the total number of cells 
on and in the collagen gel compared with IgG control (136.0   ±   
18.2 vs. 320.4   ±   53.6; P = 0.001;   Fig. 3 A  ), suggesting a defect 
in the commitment to undergo EMT. These cells display pheno-
typic activation (loss of cell  –  cell junctions and separation be-
  Figure 3.       Effects of leptin, STAT3, and Akt inhibition on EMT in the endocardial cushions.   Quantiﬁ  cation of endocardial (black bars) and mesenchymal cell 
numbers (gray bars) after AVCs were cultured with 5   μ  g/ml IgG or     -leptin antibody (A), vehicle or 1 mM PpYLKTK (D), and DMSO or 5   μ  M Akt inhibitor XI (G). 
Cellular morphology was evaluated by F-actin staining (red): IgG (B),     -leptin antibody (C), vehicle (E), PpYLKTK (F), DMSO (H), and Akt inhibitor XI (I). 
Vimentin staining after treatment with IgG (J),     -leptin antibody (K), DMSO (L), and Akt inhibitor XI (M). DAPI, blue. Error bars represent SD. *, P   <   0.05.     371 LEPTIN MODULATES CARDIAC EMT   •   NATH ET AL.
in embryonic EMT ( Cho et al., 2001a , b ;  Peng et al., 2003 ;  Larue 
and Bellacosa, 2005  ;   Yang et al., 2005; Dummler et al., 2006  ). 
However, ex vivo assays provide a system to conduct functional 
experiments on mammalian embryos. 
  To determine whether the Akt pathway may be present in 
the embryonic heart, immunofl  uorescent localization of Akt 
(antibody detects Akt1, 2, and 3) was performed on embryonic 
hearts excised from timed pregnant matings at stages of endo-
cardial cushion morphogenesis before EMT (E8.5) and during 
EMT (E9.5). The presence of Akt in the endocardial cells before 
EMT ( Fig. 4 A ) suggests recruitment of Akt signaling in the endo-
cardial response to EMT inductive stimuli. The expression of 
Akt in mesenchymal cells (  Fig. 4 B  ) signifi  es a potential role 
in maintenance of the mesenchymal phenotype after EMT or 
participating in invasion-associated cellular activities. The ex-
pression patterns of leptin receptor and Akt prompted the inves-
tigation of the Akt pathway as a downstream mediator of leptin 
action. Inhibition of leptin in the AVC explants resulted in de-
creased Akt phosphorylation at serine 473 after 2 h (  Fig. 4 C  ). 
The intensity of the bands was measured using Quantity One 
software to determine relative phosphorylation levels. In the 
displayed blot, 89% of total Akt was phosphorylated in control 
hearts compared with 62% after leptin antibody treatment for 
expression of F-actin (  Fig. 3 C  ) compared with the elongated 
cells with a fi  lamentous pattern of F-actin present in control cells 
(  Fig. 3 B  ). Accordingly, 76% of leptin antibody  –  treated cells 
maintained an epithelial morphology compared with 33% of 
IgG-treated cells (  Fig. 3 A  , black bars). Compared with the con-
trol, mesenchymal cells in the leptin antibody group displayed 
decreased cellular elongation. 
  The morphological appearance of the cells present on the 
collagen is activated (i.e., the endocardial cells have undergone 
lateral cell – cell separation and appear rounded but have not trans-
formed). In cultures treated with leptin antibody, immunofl  uo-
rescent staining for vimentin, a marker of mesenchyme, detected 
reduced levels of vimentin in a cortical expression pattern ( Fig. 3 K ) 
compared with the control (  Fig. 3 J  ). This phenotype suggests an 
inability to complete or an early arrest of the EMT program. 
  Leptin induces Akt phosphorylation, 
and AVCs cultured with Akt inhibitors 
phenocopy leptin inhibition 
  To further understand the abrogation of EMT induced by leptin 
sequestration, signaling mechanisms downstream of leptin re-
ceptor engagement were considered. The leptin receptor, a mem-
ber of the class I cytokine receptor family with sequence and 
structural homology to glycoprotein 130, leukemia inhibitory 
factor, and OSM receptors, is encoded by the   db   gene.  All  six 
isoforms contain a JAK-binding site, but only the long form of 
the receptor Ob-R contains the motifs necessary for STAT sig-
naling, providing the mechanism by which leptin signals in the 
majority of tissues studied (  Hegyi et al., 2004  ). The exquisite 
specifi  city of STAT recruitment is thought to lie in the JAK2-
phosphorylated tyrosines and fl  anking amino acid residues of 
the SH2-binding domain of the cytokine receptor ( Ghilardi et al., 
1996 ;  Ihle, 1996 ). Leptin signal transduction through JAK2/STAT3 
has been demonstrated to regulate many of leptin  ’  s effects on 
endothelial cell biology (  Heim et al., 1995  ). 
  To establish whether STAT3 plays a role in cardiac EMT, 
a peptide inhibitor of STAT3 (PpYLKTK-mts, a cell-permeable 
analogue of the STAT3-SH2 domain that prevents dimerization 
of STAT3 proteins and subsequent translocation into the nu-
cleus) was used. Surprisingly, STAT3 inhibition (  Fig. 3 F  ) did 
not recapitulate the phenotypic effects of leptin inhibition. 
There was no signifi  cant difference in the total number of cells 
or in the number of mesenchymal cells between PpYLKTK and 
the control (  Fig. 3 D  ). 
  Leptin  ’  s downstream signaling events are complex. In cell 
lines, leptin activates multiple signaling pathways, including 
the mitogen-activated protein kinase, PI3K, PKC, phospho-
diesterase, PLC, and JNK pathways (  Sweeney, 2002; Fr  ü  hbeck, 
2006  ). Based on these studies, other leptin targets were consid-
ered, in particular the PI3K  –  Akt pathway, which has gained 
much attention in cancer EMT, migration, and cardiovascular 
survival. In cancer, aberrant Akt signaling has been implicated 
in cell transformation via induction of Snail and down-regulation 
of epithelial cadherin (  Grille et al., 2003  ). To date, the role of 
Akt in EMT is based on experiments in cell lines, which do not 
provide the appropriate physiological context. Unfortunately, Akt 
knockout mice provided little information concerning their role 
  Figure 4.       Akt localization in the endocardial cushion and phosphory-
lation by exogenous leptin.   (A and B) Akt immunoﬂ  uorescence  staining 
(red) was performed on embryonic hearts excised just before EMT (A) and 
during EMT (B). (C and D) Representative Western blots for pAkt (serine 
473) and Akt in AVCs treated with 5   μ  g/ml     -leptin antibody (C) or re-
combinant leptin (50, 100, and 500 pM for 30 min; D). DAPI, blue. Myo, 
myocardium; En, endocardium; Mes, mesenchyme; CJ, cardiac jelly.     JCB • VOLUME 181 • NUMBER 2 • 2008  372 
pAkt levels compared with the control. These doses did not in-
duce the phosphorylation of STAT3 at serine 727 and tyrosine 705 
(unpublished data). 
  Functional experiments were performed using pharmaco-
logical inhibitors of Akt1  –  3 (Akt inhibitor IV or XI) in the ex 
vivo AVC assay. Treatment with Akt inhibitor XI, which inhibits 
the kinase domain of Akt, resulted in a signifi  cant decrease in the 
total number of cells present on and in the gel compared with 
the DMSO control (156.4   ±   18.2 vs. 356.4   ±   21.5; P   <   0.0001; 
  Fig. 3 G  ). The number of mesenchymal cells was signifi  cantly 
2 h (  Fig. 4 C  ), resulting in an     30% decrease in pAkt. The po-
tential role of Akt was further supported by the observation 
that dose-dependent induction of Akt phosphorylation at serine 
473 occurs in AVCs treated with exogenous recombinant leptin 
(50, 100, and 500 pM) for 30 min (  Fig. 4 D  ). In   Fig. 4 D  , initial 
relative phosphorylation levels in control hearts was 16%. After 
the addition of 50, 100, and 500 pM of recombinant leptin 
for 30 min, the percent total Akt that was phosphorylated in-
creased to 26, 57, and 80%, respectively. At the highest dose of 
recombinant leptin, there was a fi  vefold increase in relative 
  Figure 5.       Inhibition of leptin or Akt does not affect Snail 
or VE-cadherin but alters     v    3 integrin levels.   (A and B) 
Representative Western blots of VE-cadherin and Snail (A) 
after treatment with either 5   μ  g/ml IgG or     -leptin anti-
body and either DMSO or 5   μ  M Akt inhibitor XI.     -Tubulin 
was used as a loading control. Representative Western 
blot of     v and     3 integrins (B) after immunoprecipitation 
of     v    3 integrins in AVCs treated with 5   μ  g/ml IgG com-
pared with 5   μ  g/ml     -leptin antibody or DMSO compared 
with 5   μ  M Akt inhibitor XI. (C)     v    3 Integrin immuno-
ﬂ  uorescence staining (red) was performed on embryonic 
hearts excised just before EMT (C). (D) Quantiﬁ  cation of 
endocardial (black bars) and mesenchymal cell numbers 
(gray bars) after AVCs were cultured with 2   μ  g/ml IgG 
or LM609 antibody. (E and F) Cellular morphology was 
evaluated by F-actin staining (red): 2   μ  g/ml IgG (E) or 
LM609 antibody (F). DAPI, blue. Myo, myocardium; En, 
endocardium; Mes, mesenchyme; CJ, cardiac jelly. Error 
bars represent SD. *, P   <   0.0001.     373 LEPTIN MODULATES CARDIAC EMT   •   NATH ET AL.
phenocopy TGF-  2 inhibition in which there is outgrowth of endo-
thelial cells, retention of cell  –  cell contacts, and near-complete 
inhibition of EMT (  Camenisch et al., 2002  ). Collectively, these 
data suggest that a pathway downstream of or parallel to TGF-    
leads to the defects induced by leptin inhibition. 
  Perturbation of leptin or Akt pathways 
alters     v    3 integrin levels 
 Explants  from TGF-    and endothelial     -catenin mutants as well 
as explants treated with cyclosporine A (to inhibit calcineurin) 
all exhibit the outgrowth of endocardial sheets, leading to nor-
mal total cell numbers but a lack of EMT (  Camenisch et al., 
2002  ;   Chang et al., 2004  ;   Liebner et al., 2004  ). After dissolu-
tion of cadherin junctions within the monolayer, the freed 
endo  cardial cells must interact with and adhere to the sur-
rounding matrix. Therefore, the substantial defect in total cell 
number may reflect an endothelial cell adhesion defect. To a 
large extent, endothelial cells mediate adhesion to extracellu-
lar matrix through cell surface integrin receptors (  Stupack and 
Cheresh, 2002  ). Upon initiation of endothelial migration, the 
distri bution  and  levels of integrins change. In particular,    v  3 
integrin becomes dramatically induced and binds to the provi-
sional matrix facilitating adhesion and migration (  Stupack and 
Cheresh, 2002  ). 
  Just before EMT (E8.5), embryonic hearts express    v  3 
integrin (  Fig. 5 C  ). Inhibition of leptin or Akt resulted in de-
creased    v   3 integrin protein levels (  Fig. 5 B  ). Further hearts 
cultured with a function-blocking antibody to    v  3  integrin 
(  Fig. 5 F  ) phenocopied the leptin inhibition morphological de-
fects (  Fig. 3 C  ), suggesting decreased adhesion as one of the 
consequences of the loss of leptin. Functional inhibition of 
   v   3 integrin resulted in a signifi  cant decrease in the total num-
ber of cells that migrated onto and into the gel compared with 
IgG control (191   ±   1.0 vs. 366.7   ±   15.1; P   <   0.0001;   Fig. 5 D  ). 
Fewer cells underwent EMT compared with the control (number 
of mesenchymal cells = 45.0   ±   5.3 vs. 243   ±   12.3; P = 0.0008; 
  Fig. 5 D  , gray bars), with the majority of total cells remaining 
epithelial after functional inhibition of    v  3  integrin  (76.4  vs. 
33.7%) and displaying a cortical distribution of F-actin (  Fig. 5,   
compare   F   with E). These data demonstrate an adhesion defect 
possibly mediated via    v   3 integrin; however, endothelial cells 
express several other integrins that may contribute to the adhe-
sion defect induced by leptin inhibition. 
  Inhibition of leptin or Akt reduces invasion 
and MMP2 enzymatic activity 
  Confocal z-plane images of F-actin  –  stained cultures revealed 
decreased invasion after leptin or Akt inhibition (  Fig. 6, B and C  ) 
compared with the control (  Fig. 6 A  ). In control AVC cultures, 
    50% of total cells invade into the collagen gel, whereas after 
leptin or Akt inhibition, 25% of total cells invade (P   <   0.0001; 
  Fig. 6 D  ). Mesenchymal cell migration into the endocardial 
cushion in vivo or into the collagen gel ex vivo requires coordi-
nated dissolution of adhesion molecules followed by activation 
of pericellular protease activity (  Person et al., 2005  ). Proteolysis 
of extracellular matrix components facilitates cellular travel 
through the complex matrices of the endocardial cushion and 
less after Akt inhibition compared with the DMSO control (38.2   ±   
5.3 vs. 238.4   ±   20.0; P   <   0.0001;   Fig. 3 G  , gray bars). The ma-
jority of cells (75%) remained epithelial compared with the con-
trol (33%), and an epithelial pattern of F-actin was observed 
(  Fig. 3,   compare I with H). Similar results were obtained with 
Akt inhibitor VI and PI3K inhibitor LY294002 (unpublished 
data). Vimentin staining of cultures treated with Akt inhibitor XI 
detected reduced levels of vimentin in a cortical expression pat-
tern (  Fig. 3 M  ) compared with the control (  Fig. 3   L). 
  Akt inhibition (  Fig. 3 I  ) phenocopied the morphological 
defects of leptin inhibition (  Fig. 3 C  ). Furthermore, quantifi  ca-
tion of the defects revealed similar effects on total cell number 
and EMT, which supports the hypothesis of an Akt pathway 
downstream of leptin receptor engagement. However, the in-
volvement of other signaling pathways downstream of leptin 
receptor engagement and activation remained possible. There-
fore, the mitogen-activated protein kinase, PKC, and protein 
phosphatase 1/protein phosphatase 2A pathways were evalu-
ated using pharmacological inhibitors (PD98059, G  ö  6983, and 
okadaic acid, respectively) at a range of doses. All of these 
resulted in normal cell number and EMT (unpublished data). 
Of note, high doses of G ö 6983 and okadaic acid affected myocar-
dial survival and resulted in death of the explant tissue. 
  Perturbation of leptin or Akt pathways 
does not affect snail or VE-cadherin levels 
 TGF-    ligands and receptors display distinct and dynamic spa-
tiotemporal patterns in the embryonic heart and induce cardiac 
EMT (  Camenisch et al., 2002  ;   D  ü  nker and Krieglstein, 2002  ). 
After induction of endothelial cells to the EMT pathway by 
myocardial-derived factors such as TGF-   ,  cell – cell  junctions 
must be dissociated. Snail-induced degradation, relocalization, 
and transcriptional repression of cadherins has been intensely 
studied and is widely appreciated in multiple model organisms and 
cell lines (  Cano et al., 2000  ;   Carver et al., 2001  ;   Nieto, 2002  ). 
This repression is believed to be the mechanism by which Snail 
participates in EMT and/or maintenance of the mesenchymal/
migratory phenotype. TGF-     acting upstream of Snail in this 
pathway has become one of the most studied models of EMT 
(  Frid et al., 2002  ;   Peinado et al., 2003  ;   Nawshad et al., 2005  ; 
  Zavadil and Bottinger, 2005  ). To further elucidate the function 
of leptin, the interaction of leptin in this established pathway 
was assessed by determining the levels of Snail and vascular 
endothelial (VE) cadherin by Western blotting 48  –  72 h after 
treatment. A failure of Snail induction would result in the per-
sistence of VE-cadherin and the inability to undergo EMT. 
However, the inhibition of leptin and Akt resulted in similar lev-
els of Snail and VE-cadherin as control cultures actively under-
going EMT (  Fig. 5 A  ), suggesting that this pathway is intact. 
Furthermore, a monolayer of cells was not observed on the col-
lagen gel after leptin or Akt inhibition (  Fig. 3, C and I  , respec-
tively), which would be expected in the event of the persistence 
of VE-cadherin. Instead, the cells appeared separated from each 
other, which is consistent with a loss of cell  –  cell junctions. 
Additionally, supplementation of recombinant TGF-   2  into  the 
media bathing the explants did not rescue the defects induced 
by leptin antibody (unpublished data), nor did leptin inhibition JCB • VOLUME 181 • NUMBER 2 • 2008  374 
Culture media was collected 48 h after addition of the indicated 
treatment. Leptin antibody and Akt XI inhibitor decreased both 
pro-MMP2 (72 kD) and active MMP2 (62 kD;   Fig. 6, E and F  ). 
Quantity One software was used to measure the band inten-
sities from digital images of the zymograms. Treatment with 
10   μ  g/ml leptin antibody resulted in a 38% decrease in total 
MMP2 levels (control = 7,316,033   ±   1,332,255 pixels; leptin 
antibody = 4,475,740   ±   970,559 pixels;   n   = 3; P   <   0.05). Treat-
ment with 5   μ  M Akt inhibitor XI resulted in a 40% decrease 
may release cytokines/chemokines bound to the cardiac jelly. 
The MMP family of proteases modifi   es  cell – matrix  interactions 
by digesting extracellular matrices to facilitate cell spread-
ing/migration. Inhibition of MMPs with the broad spectrum in-
hibitor GM6001 in murine AVC cultures does not block EMT 
but inhibits the migration of mesenchymal cells into the colla-
gen gel (  Enciso et al., 2003  ). 
 The  profi  le of latent and active gelatinases (MMP2 and 9) 
secreted into the media by the AVCs was assessed by zymography. 
  Figure 6.       Inhibition of leptin or Akt reduces invasion and MMP2 enzymatic activity.   (A  –  C) Confocal z-plane slices through F-actin  –  stained cultures demon-
strating cell migration from the surface of the collagen gel (white lines) in control (A),     -leptin  –   (B), and Akt inhibitor XI (C)  –  treated cultures. (D) Percentage 
of total cells that invade the collagen gel (controls on left, treatment on right): 5   μ  g/ml IgG versus     -leptin antibody (gray bars) and DMSO versus 5   μ  M 
Akt inhibitor XI (black bars). (E and F) Zymography of the media bathing the explants 48 h after treatment: 5   μ  g/ml IgG, 5 and 10   μ  g/ml     -leptin antibody (E); 
and DMSO, 1 and 5   μ  M Akt inhibitor XI (F). (G  –  J) Immunoﬂ  uorescence (red) for MMP2 (G and I) and MMP14 (H and J) was performed on embryonic 
hearts excised at E8.5, just before EMT (G and H), and at E9.5, during EMT (I and J). DAPI, blue. Myo, myocardium; En, endocardium; Mes, mesenchyme; 
CJ, cardiac jelly. Error bars represent SD. *, P   <   0.0001.     375 LEPTIN MODULATES CARDIAC EMT   •   NATH ET AL.
  Inhibition of leptin or Akt induces increased 
rates of cell death 
  The cell survival properties of leptin have been described in 
multiple cell types in the vascular, bone, and nervous systems 
(  Artwohl et al., 2002  ;   Najib and Sanchez-Margalet, 2002; 
Gordeladze and Reseland, 2003  ;   Guo et al., 2007  ). Therefore, 
an alternative explanation for changes in total cell number may 
be leptin  ’  s effects on proliferation and apoptosis. To evaluate this 
hypothesis, TUNEL staining was performed on cultures treated 
with leptin antibody (  Fig. 7 B  ) or Akt inhibitor XI (  Fig. 7 D  ). 
Inhibition of leptin resulted in 49.8  ±   4.3% of total cells display-
ing TUNEL reactivity compared with 17   ±   3.4% in the control 
group (  n   = 3; P   <   0.0001;   Fig. 7 E  ). Similarly, inhibition of Akt 
resulted in 34.4   ±   5.3% of total cells displaying TUNEL reactiv-
ity compared with 10   ±   2.8% in the control group (  n   = 3; P   <   
0.0009;   Fig. 7 E  ). A 2.8- or 3.4-fold induction in cell death was 
detected after treatment with     -leptin antibody or Akt inhibitor 
XI, respectively, suggesting that leptin/Akt signaling plays a 
role in cell survival during cardiac EMT or that the failure of 
normal differentiation results in cell death. 
in total MMP2 levels (control = 7,193,127   ±   905,809 pixels; 
Akt inhibitor XI = 4,247,400   ±   350,421 pixels;   n   = 3; P   <   0.05). 
Heart/gel lysates displayed a similar pattern of decreased MMP2 
(unpublished data). As a negative control, the addition of EDTA, 
an MMP inhibitor, to the incubation buffer of a duplicate 
  zymogram completely abolished the degradation of gelatin (un-
published data). 
  Presumably, the MMP2 detected in the media is generated 
initially in greater part by the myocardium and modestly by 
the endocardium. A series of immunofl  uorescently labeled em-
bryonic hearts from developmental time points during endo-
cardial cushion morphogenesis revealed MMP2 expression to 
be strongly present in the myocardium and weakly present in 
the endocardium (  Fig. 6 G  ). During EMT and migration, the 
mesenchyme intensely expresses MMP2 (  Fig. 6 I  ). In accor-
dance with the idea of MMP2 enzymatic activity in multiple 
cell types in the embryonic heart, MMP14, a key regulator of 
MMP2 activity that acts by cleaving and activating pro-MMP2 
at the membrane, is present in an overlapping pattern as MMP2 
(  Fig. 6, H and J  ). 
  Figure 7.       Inhibition of leptin or Akt induces apoptosis.   (A  –  D) TUNEL staining (red) after treatment with 5   μ  g/ml     -leptin antibody (B) or 5   μ  M Akt inhibitor 
XI (D) compared with the control (A and C, respectively). DAPI, blue. (E) Percentage of total cells that are TUNEL positive (controls on left, treatment on right): 
IgG versus     -leptin antibody (gray bars) and DMSO versus Akt inhibitor XI (black bars). (F) Representative Western blot of PCNA after treatment with either 
5   μ  g/ml IgG or     -leptin antibody and either DMSO or 5   μ  M Akt inhibitor XI.     -Tubulin was used as a loading control. (G  –  I) Percentage of total cells that 
are TUNEL positive (G), total cells present in and on the gel (H), and percentage of total cells undergoing EMT (black bars) or migrating into the collagen 
gel (gray bars; I) after treatment with IgG,     -leptin antibody, or     -leptin antibody plus 40 mM z-VAD. Error bars represent SD. Bar, 40   μ  m. *, P   <   0.05.     JCB • VOLUME 181 • NUMBER 2 • 2008  376 
binant leptin during pregnancy or heterozygous matings. There-
fore, the ex vivo AVC explant assay was used to overcome the 
previously stated complications of studying the role of leptin in 
early postimplantation embryonic development. Using this as-
say, we demonstrated that leptin depletion in the media bathing 
the explants results in attenuated cardiac EMT. Our results demon-
strate that leptin is required for but is not suffi  cient for EMT. 
  Leptin interacts with a plethora of cell signaling elements 
( Bjorbaek et al., 1997 ;  Sweeney, 2002; Fr ü hbeck, 2006 ). We were 
particularly interested in leptin  ’  s interaction with the PI3K  –  Akt 
pathway because this system has been associated with migration, 
cancer EMT, and cardiovascular survival. In many human can-
cers, Akt is activated, endowing tumor cells with motile and inva-
sive properties (  Altomare and Testa, 2005  ). The defi  nitive study 
demonstrating the role of Akt in EMT is based on experiments 
using squamous cell carcinoma lines, which do not provide the 
appropriate physiological context (  Grille et al., 2003  ). Several 
developmental milestones rely on EMT, including gastrulation, 
neural crest formation, cardiac morphogenesis, and sclerotome 
formation. Unfortunately, Akt knockout mice provided little in-
formation concerning their role in embryonic EMTs. To over-
come the diffi  culties of performing functional experiments on 
mammalian embryos in utero, we used ex vivo AVC assays that 
provide a system to conduct functional experiments on complex, 
intact mammalian embryonic tissue. We demonstrate that in-
hibition of Akt in AVC cushions inhibits EMT, which provides 
the fi  rst direct evidence of the involvement of Akt in embryonic 
EMT. The defects induced by Akt inhibition phenocopied leptin 
inhibition, suggesting that Akt may be downstream of leptin re-
ceptor engagement. Furthermore, recombinant leptin induced 
Akt phosphorylation, whereas leptin inhibition reduced Akt 
phosphorylation. Given the lack of the phenotypic similarity of 
inhibition of several other major cell signaling pathways (mitogen-
activated protein kinase, PKC, and phosphatase 1/protein phos-
phatase 2A), Akt is suspected to be the primary intracellular 
pathway mediating leptin  ’  s actions in the endocardial cushion. 
However, given that inhibition at the ligand level often disrupts 
numerous signaling components, the participation of other intra-
cellular signaling pathways cannot be defi  nitively excluded. 
  Targets downstream of or parallel to TGF-   /Snail-driven 
dissolution of VE-cadherins are speculated to underlie the EMT 
defect induced by leptin inhibition. After cell  –  cell detachment, 
signals transmitted between the endocardial cell and its extra-
cellular environment within the cardiac jelly or collagen gel 
guide cell behaviors. In endothelial cells, these interactions are 
largely mediated by integrin receptors (  Stupack and Cheresh, 
2004  ). The integrin family is comprised of a multitude of      and 
    subunits that noncovalently associate in various heterodimeric 
combinations to produce 24 different      -heterodimeric  recep-
tors on the cell surface that participate in bidirectional signal-
ing. The balance between cell adhesion and migration relies on 
this bidirectional signaling between the cytosol and extracellu-
lar environment. However, little is known regarding heart devel-
opment and integrins, although    3,    6,     7, and    1  integrins  are 
expressed in the embryonic heart (  Hescheler and Fleischmann, 
2000  ). Furthermore, integrin-linked kinase mediates EMT in mul-
tiple epithelia potentially via the phosphorylation of      integrins, 
  Proliferation was evaluated by Western blotting for prolif-
erating cell nuclear antigen (PCNA) 48 h after treatment with 
either leptin antibody or Akt inhibitor XI. The data were nor-
malized to    -tubulin  ( n   = 5). There was not a signifi  cant change 
in control versus leptin antibody treatment or control versus Akt 
XI inhibitor treatment (  Fig. 7 F  ). 
  To differentiate between the effects of leptin on EMT ver-
sus cell survival, the caspase inhibitor Z-VAD was added to the 
cultures. Hearts treated with     -leptin antibody plus Z-VAD had 
reduced levels of TUNEL-positive cells compared with leptin 
antibody alone (14.0   ±   2.0 vs. 30.6   ±   8.9%;   n   = 3; P   <   0.05), 
similar to the control (18.6   ±   3.4%;   Fig. 7 G  ). Concomitantly, 
the total number of cells present in and on the gel after treat-
ment with leptin antibody plus Z-VAD was increased compared 
with leptin antibody alone (584   ±   143 vs. 226   ±   9;   n   = 3; P   <   
0.05) and surpassed that of the control (423   ±   112;   Fig. 7 H  ). 
The decrease in EMT and migration observed after leptin inhi-
bition was not rescued by the addition of Z-VAD, suggesting 
that the decrease in differentiation and migration is independent 
of the induction of apoptosis (  Fig. 7 I  ). 
  Discussion 
  Leptin affects diverse cellular processes that modulate angiogen-
esis, metabolism, and reproduction. In this study, modulation of 
cardiac EMT and migration were found to be novel roles of leptin, 
demonstrating a functional role of the fi  rst Il-6 member in cardiac 
EMT. Robust EMT is regulated by the interplay between differ-
ential responses of distinct cell types. Leptin and leptin receptor 
localization patterns suggest a pathway of EMT by which myo-
cardial-derived ligand acts on endocardial receptors to drive 
EMT, which is consistent with the known cell-autonomous path-
way of cardiac EMT (  Fig. 8  ). Interestingly, the increasing ex-
pression of leptin as mesenchymal cells migrate toward the 
myocardium (  Fig. 1 C  ) and the strong presence of leptin in the 
mesenchyme later in cushion morphogenesis (  Fig. 1, E and F  ) 
may suggest that leptin is a marker of mature mesenchyme. The 
spatial expression pattern of leptin and leptin receptor in the myo-
cardium also suggests a role as an autocrine mediator of myocar-
dial biology. This fi  nding is consistent with the observation that 
  ob/ob   mice develop cardiac hypertrophy (  Barouch et al., 2003  ). 
Furthermore, STAT3 may mediate these aspects of leptin, as 
cardiomyocyte-targeted STAT3 deletion causes postnatal death 
by heart failure (  Jacoby et al., 2003  ). Leptin appears to play a role 
not only in myocardial plasticity but in endothelial biology, as 
  ob/ob   mice display attenuated angiogenesis in response to injury 
( Suganami et al., 2004 ). Immunofl  uorescence experiments in em-
bryonic hearts failed to demonstrate STAT3 in the endocardium 
(unpublished data), and pharmacological inhibition of STAT3 
did not affect cardiac EMT. Concomitantly, STAT3 endothelial-
targeted transgenic mice are viable and healthy, with no apparent 
cardiac defect (  Kano et al., 2003  ). Therefore, the effects of the 
leptin-STAT3 axis in the myocardium are likely independent of 
leptin  ’  s effects on the endocardium. 
 Leptin  ( ob/ob  ) and leptin receptor (  db/db )  mutant  mice 
have not been reported to have developmental defects. However, 
such experiments are confounded by the requirement of recom-377 LEPTIN MODULATES CARDIAC EMT   •   NATH ET AL.
addition of a function-blocking    v   3 antibody are all consis-
tent with the hypothesis that leptin signaling modulates    v  3 
expression via an Akt pathway during cardiac EMT. Supporting 
this hypothesis is a recent study documenting leptin-driven 
blastocyst adhesion via the up-regulation of    v  3  expression 
(  Yang et al., 2006  ). Therefore, the signifi  cant decrease in total 
cell number concomitant with the dissolution of cell  –  cell junc-
tions after leptin inhibition suggests that leptin may affect the 
adhesion of endocardial cells to matrix. Decreased adhesive-
ness to the collagen gel or cardiac jelly may cause decreased 
EMT and migration and may thus affect subsequent valvular 
development. However, further evaluation of additional adhe-
sion receptors and matrix molecules are required to fully appre-
ciate the role of leptin in endocardial adhesion. 
  An alternative hypothesis to explain differences in total 
cell number is the substantial negative effect of leptin and 
Akt inhibition on cell survival. However, supplementation 
with Z-VAD to inhibit apoptosis also resulted in decreased 
EMT. Cell death may be the default pathway in a population 
of cells in which differentiation is unable to occur. There-
fore, we speculate that the primary effects are impaired dif-
ferentiation, which subsequently leads to cell death, and reduced 
total cell number. 
  After adhesion and differentiation, mesenchymal cells 
elongate and migrate. Recently, leptin has been reported to 
modulate actin cytoskeleton dynamics via RhoA/Rock (  Zeidan 
et al., 2007  ). Consistent with this study, we demonstrate a fi  la-
mentous expression pattern of leptin in the mesenchymal cells 
of the remodeling endocardial cushion. Elongated mesenchy-
mal cells invade the collagen gel or cardiac jelly via MMP2 
(  Song et al., 2000; Enciso et al., 2003  ). Inhibition of leptin re-
duces MMP2 levels and activity, leading to decreased invasion 
into the collagen gel. Leptin is known to increase the levels and 
activity of MMP2 and MMP9 in human umbilical endothelial 
cells and the rat corneal angiogenesis assay, suggesting a role 
for leptin in matrix remodeling and migration (  Park et al., 2001; 
Lee et al., 2005  ;   Moon et al., 2007  ). Furthermore, Akt, a major 
signaling pathway in cell migration and known activator of MMP2, 
mediates migration in leptin-treated endothelial cells (  Goetze 
et al., 2002  ;   Jin et al., 2007  ). Therefore, in the embryonic heart, 
the requirement of MMPs in the migratory events during car-
diac EMT may be fulfi  lled by leptin acting upstream of Akt and, 
thereby, contributing to the invasive phenotype of cardiac mes-
enchymal cells. Interestingly, leptin  ’  s ability to modulate the 
expression of    v   3 integrin and MMP2 may also infl  uence the 
binding of MMP2 to the cell surface by providing the increased 
expression of    v   3 integrin, a known MMP2 tethering mole-
cule (  Brooks et al., 1996, 1998  ;   Silletti et al., 2001  ). This pos-
sibility coupled with the ability of MMPs to release ECM-bound 
growth factors and to proteolyse a broad range of cytokines 
and chemokines further broadens leptin  ’  s downstream effects 
(  Overall et al., 2002; Dean and Overall, 2007  ). Collectively, our 
observations defi  ne several roles for leptin in valvular morpho-
genesis (  Fig. 8  ); determining the range of leptin-induced effec-
tor molecules that elicit entry into EMT and how leptin integrates 
into the complex network that confers successful EMT remains 
to be deciphered. 
Akt, and GSK3     (  Li et al., 2003  ;   Ahmed et al., 2006  ;   Shimizu 
et al., 2006  ;   Weaver et al., 2007  ). 
  After leptin or Akt inhibition, only a few cells are able to 
delaminate from the explant tissue. These cells are able to dis-
perse from each other but appear rounded or short rather than 
elongated with fi  lopodia. This phenotype suggests that the cells 
are not able to interact with their environment in a normal man-
ner, presumably via integrin engagement. The cardiac jelly con-
sists of a complex network of matrix molecules and proteoglycans, 
including laminins, collagens, and fi  bronectin, whereas the ex 
vivo assay consists of the matrix secreted by the explant and the 
type I collagen gel the explant is planted on. Although several in-
tegrins could potentially mediate endocardial attachment,    v  3 
integrin became an attractive candidate because of its known 
roles in endothelial cell migration and its repertoire of ligands 
(including fi  bronectin, vitronectin, and proteolysed forms of col-
lagen and laminin;   Stupack and Cheresh, 2004  ). 
  Our data illustrating a reduction in    v  3  integrin  ex-
pression in explants after leptin or Akt inhibition combined with 
the data demonstrating a reduction of total cell numbers after 
  Figure 8.       Summary of leptin  ’ s roles in the endocardial cushion.   The spa-
tiotemporal pattern of leptin and leptin receptor depicts a pathway by 
which myocardial-derived leptin ligand engages with endocardial leptin 
receptors to drive EMT and migration, which is consistent with the known 
cell-autonomous pathway of cardiac EMT. In an ex vivo functional assay, 
loss of leptin abrogates adhesion, EMT, cell survival, and migration, poten-
tially via Akt. The leptin pathway is independent of the TGF-    /Snail-driven 
dissolution of VE-cadherin. Interestingly, the speciﬁ  c  effector  molecules 
disrupted by loss of leptin in the endocardial cushion are known media-
tors of adhesion, migration, and differentiation. Leptin  ’  s role in adhesion 
of endocardial cells may occur through     v    3 integrin receptor, whereas 
leptin-driven proteolytic activity and invasion of mesenchymal cells may be 
mediated by MMP2. Furthermore, MMPs modulate growth factor release 
and receptor availability and may affect morphogen gradients across the 
cardiac jelly and, thus, signaling cascades. The potential branch points in 
the leptin signaling pathway and cross talks with other pathways remain 
to be uncovered. Ultimately, leptin signaling affects adhesion, EMT, cell 
survival, and migration within the embryonic heart.     JCB • VOLUME 181 • NUMBER 2 • 2008  378 
  In situ cell death detection 
  Cell death was evaluated using the In Situ Cell Death Detection kit (TMR 
red; Roche) according to the manufacturer  ’  s instructions. Subsequently, cells 
were counterstained with DAPI, and the percentage of apoptotic to total 
cells was calculated. To inhibit apoptosis, 40   μ  M Z-VAD  –  ﬂ  uoromethylketone 
(BD Biosciences) was added every 24 h. 
  Statistics 
  The data were analyzed by   t   test (StatView; SAS Institute, Inc.) and re-
ported as the mean   ±   SD. 
  This study was supported by National Institutes of Health grant R37HL28373 
to J.A. Madri, grant HG02357 to M. Snyder, and grant 5T32 GM07499 to 
A.K. Nath. 
Submitted:   29 August 2007 
Accepted:   20 March 2008 
  References 
   Ahmed ,   N. ,   S.    Maines-Bandiera ,   M.A.    Quinn ,   W.G.    Unger ,   S.    Dedhar ,  and   N.  
 Auersperg .   2006 .   Molecular  pathways  regulating  EGF-induced  epithelio-
mesenchymal transition in human ovarian surface epithelium.       Am. J. 
Physiol. Cell Physiol.     290 : C1532  –  C1542 .    
   Altomare ,   D.A. ,  and   J.R.    Testa .   2005 .   Perturbations  of  the  AKT  signaling  path-
way in human cancer.       Oncogene   .    24 : 7455  –  7464 .    
   Antczak ,   M. ,  and   J.    Van  Blerkom .   1997 .   Oocyte  infl  uences on early develop-
ment: the regulatory proteins leptin and STAT3 are polarized in mouse 
and human oocytes and differentially distributed within the cells of the 
preimplantation stage embryo.       Mol. Hum. Reprod.     3 : 1067  –  1086 .    
   Artwohl ,   M. ,   M.    Roden ,   T.    Holzenbein ,   A.    Freudenthaler ,   W.    Waldhausl ,  and 
 S.M.    Baumgartner-Parzer .   2002 .   Modulation  by  leptin  of  proliferation 
and apoptosis in vascular endothelial cells.       Int. J. Obes. Relat. Metab. 
Disord.     26 : 577  –  580 .    
   Asgeirsson ,   K.S. ,   K.    Olafsdottir ,   J.G.    Jonasson ,  and   H.M.    Ogmundsdottir .   1998 . 
  The effects of IL-6 on cell adhesion and e-cadherin expression in breast 
cancer.     Cytokine   .    10 : 720  –  728 .    
   Barouch ,   L.A. ,   D.E.    Berkowitz ,   R.W.    Harrison ,   C.P.    O ’ Donnell ,  and   J.M.    Hare . 
  2003  .   Disruption of leptin signaling contributes to cardiac hypertrophy 
independently of body weight in mice.       Circulation   .    108 : 754  –  759 .    
   Bernanke ,   D.H. ,  and   R.R.    Markwald .   1982  .   Migratory behavior of cardiac 
cushion tissue cells in a collagen-lattice culture system.       Dev. Biol.   
 91 : 235  –  245 .    
   Bjorbaek ,   C. ,   S.    Uotani ,   B.    da  Silva ,  and   J.S.    Flier .   1997 .   Divergent  signaling 
capacities of the long and short isoforms of the leptin receptor.       J. Biol. 
Chem.     272 : 32686  –  32695 .    
   Brooks ,   P.C. ,   S.    Stromblad ,   L.C.    Sanders ,   T.L.    von  Schalscha ,   R.T.   Aimes ,   W.G.  
 Stetler-Stevenson ,   J.P.    Quigley ,  and   D.A.    Cheresh .   1996 .   Localization  of 
matrix metalloproteinase MMP-2 to the surface of invasive cells by inter-
action with integrin alpha v beta 3.       Cell   .    85 : 683  –  693 .    
   Brooks ,   P.C. ,   S.    Silletti ,   T.L.    von  Schalscha ,   M.    Friedlander ,  and   D.A.    Cheresh . 
  1998  .   Disruption of angiogenesis by PEX, a noncatalytic metalloprotein-
ase fragment with integrin binding activity.       Cell   .    92 : 391  –  400 .    
   Camenisch ,   T.D. ,   D.G.    Molin ,   A.    Person ,   R.B.    Runyan ,   A.C.    Gittenberger-de 
Groot ,   J.A.    McDonald ,  and   S.E.    Klewer .   2002 .   Temporal  and  distinct 
TGFbeta ligand requirements during mouse and avian endocardial cush-
ion morphogenesis.       Dev. Biol.     248 : 170  –  181 .    
   Campfi   eld ,  L.A. ,  F.J.   Smith ,  Y.   Guisez ,  R.   Devos , and  P.   Burn .  1995 .  Recombinant 
mouse OB protein: evidence for a peripheral signal linking adiposity and 
central neural networks.       Science   .    269 : 546  –  549 .    
   Cano ,   A. ,   M.A.    Perez-Moreno ,   I.    Rodrigo ,   A.    Locascio ,   M.J.    Blanco ,   M.G.    del 
Barrio ,   F.    Portillo ,  and   M.A.    Nieto .   2000 .   The  transcription  factor  snail 
controls epithelial-mesenchymal transitions by repressing E-cadherin ex-
pression.     Nat. Cell Biol.     2 : 76  –  83 .    
   Carver ,   E.A. ,   R.    Jiang ,  Y.    Lan ,   K.F.    Oram ,  and   T.    Gridley .   2001 .   The  mouse  snail 
gene encodes a key regulator of the epithelial-mesenchymal transition.   
  Mol. Cell. Biol.     21 : 8184  –  8188 .    
   Cervero ,   A. ,   J.A.    Horcajadas ,   F.    Dominguez ,   A.    Pellicer ,  and   C.    Simon .   2005 . 
  Leptin system in embryo development and implantation: a protein in 
search of a function.       Reprod. Biomed. Online   .    10 : 217  –  223 .  
   Chang ,   C.P. ,   J.R.    Neilson ,   J.H.    Bayle ,   J.E.    Gestwicki ,  A.    Kuo ,   K.    Stankunas ,   I.A.  
 Graef ,  and   G.R.    Crabtree .   2004 .  A  fi  eld of myocardial-endocardial NFAT 
signaling underlies heart valve morphogenesis.       Cell   .    118 : 649  –  663 .    
   Chehab ,   F.F. ,   M.E.    Lim ,  and   R.     Lu  .   1996  .   Correction of the sterility defect in 
  homozygous obese female mice by treatment with the human recombinant 
leptin.     Nat. Genet.     12 : 318  –  320 .    
  Materials and methods 
  Mice 
  10-wk-old CD1 mice (Charles River Laboratories) were maintained under 
standard conditions. Timed matings were performed and detected by the 
presence of a vaginal plug (designated day 0.5 postconceptual). The Yale 
University Animal Care and Use Committee approved all animal protocols, 
and experimentation was performed in accordance with National Institutes 
of Health regulations. 
  Immunoﬂ  uorescence 
  Tissues were excised and frozen in optimal cutting temperature medium. 
Cryosections were stained with antibodies for F-actin (Invitrogen), leptin 
(Rocio Honigmann), leptin receptor (Rocio Honigmann), Akt (Cell Signal-
ing Technology), MMP2 (Chemicon),     v    3 (David Cheresh, University of 
California, San Diego, San Diego, CA), and MMP14 (Robert Black, 
Amgen Inc., Seattle, WA). Immunoreactivity was visualized with Alexa-
Fluor594 antibody (Invitrogen). Nuclei were stained with DAPI. 
  Image acquisition and processing 
  Immunohistochemistry was performed on frozen sections using AlexaFluor594 
secondary antibody. Slides were mounted in aqueous mounting media. AVC 
collagen gel cultures were imaged in PBS on plastic tissue culture wells 
(Thermo Fisher Scientiﬁ  c). Samples were visualized at room temperature on 
an inverted ﬂ  uorescent microscope (IX71-S1F; Olympus) with CPlan 10  ×   NA 
0.25 and LCPlanFL 20  ×   NA 0.40 objectives (Olympus) and captured with a 
digital camera (S97809; Olympus). The acquisition software used was Picture 
Frame (Optronics). Confocal images were obtained using a laser-scanning 
confocal microscope (Fluoview; Olympus) integrated with a microscope 
(IX70-S1F2; Olympus) with UplanFl 20  ×   NA 0.50 and LCPlanFl 40  ×   NA 
0.60 objectives (Olympus) and were acquired using Fluoview software 
(Olympus). Digital images were processed (cropped, brightness/contrast ad-
justed, and color balanced) using Photoshop (Adobe). 
  AVC explant assay 
  AVCs were isolated from E9.0 embryos and placed onto a 1-mg/ml type I 
rat tail collagen gel (BD Biosciences). The explants were allowed to adhere 
before the addition of media (medium 199, 1% FBS, 100 U/ml penicillin, 
100   μ  g/ml streptomycin, and 0.1% each of insulin, transferrin, and sele-
nium [Invitrogen];   Enciso et al., 2003  ). Pharmacological inhibitors were 
purchased from EMD. Five explants were plated per well. Cultures were 
stopped at 48  –  72 h. All experiments were repeated at least ﬁ  ve times. 
Some gels were ﬁ  xed with 4% PFA and stained with F-actin. En face and 
z-plane confocal images were obtained using FluoView software, and the 
number of total cells, cells that have undergone EMT (mesenchymal vs. epi-
thelial phenotype), and cells that have migrated into the gel were counted 
based on morphology and distance from the surface of the collagen gel. 
  Zymography 
  The FBS for these experiments was run through a gelatin-packed column 
to remove MMP2 and MMP9 before use in cultures. Lysates of hearts/
gels were obtained using 50 mM Tris/1% Triton X-100. Under nonreduc-
ing conditions, 25   μ  g of tissue lysate or media from cultures was run on 
a 10% zymogram gel (Bio-Rad Laboratories). The gels were washed in 
2.5% Triton X-100 and water and incubated for 72 h at 37  °  C in a 50-mM 
Tris-HCl buffer, pH 8.0, containing 5 mM calcium chloride (10 mM EDTA 
was used as a negative control). Gels were stained with Coomassie blue 
R250 and imaged. 
  Western blotting 
  Explanted hearts plus the collagen gels containing cells were harvested 
from culture conditions and lysed in radioimmunoprecipitation assay buffer 
(Millipore) supplemented with 1% SDS and inhibitor cocktails (Calbio-
chem). 25   μ  g of protein was subjected to SDS-PAGE using 4  –  15% Tris gels 
(Bio-Rad Laboratories) under reducing conditions followed by transfer to 
polyvinylidene diﬂ   uoride membranes. Primary antibodies used included 
Akt, pAkt (serine 473 and threonine 308), STAT3, pSTAT3 (serine 727 and 
tyrosine 705; Cell Signaling Technology), VE-cadherin (BD Biosciences), 
Snail (Santa Cruz Biotechnology, Inc.), and PCNA (Abcam). Blots were 
stripped and reprobed with     -tubulin (Invitrogen) as a loading control. For 
immunoprecipitation of     v    3 integrin, 100   μ  g of lysate (prepared in radio-
immunoprecipitation assay buffer) was precleared with normal serum and 
precipitated with protein A/G Sepharose. The supernatant was incubated 
with the primary antibody (anti  –      v    3 integrin), washed with decreased 
salt conditions, and electroblotted for     v and     3 integrins. 379 LEPTIN MODULATES CARDIAC EMT   •   NATH ET AL.
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